Correlation Between Amanet Management and Enlivex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amanet Management and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amanet Management and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amanet Management Systems and Enlivex Therapeutics, you can compare the effects of market volatilities on Amanet Management and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amanet Management with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amanet Management and Enlivex Therapeutics.
Diversification Opportunities for Amanet Management and Enlivex Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Amanet and Enlivex is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Amanet Management Systems and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Amanet Management is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amanet Management Systems are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Amanet Management i.e., Amanet Management and Enlivex Therapeutics go up and down completely randomly.
Pair Corralation between Amanet Management and Enlivex Therapeutics
Assuming the 90 days trading horizon Amanet Management Systems is expected to generate 0.41 times more return on investment than Enlivex Therapeutics. However, Amanet Management Systems is 2.45 times less risky than Enlivex Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 150,300 in Amanet Management Systems on September 14, 2024 and sell it today you would earn a total of 5,700 from holding Amanet Management Systems or generate 3.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Amanet Management Systems vs. Enlivex Therapeutics
Performance |
Timeline |
Amanet Management Systems |
Enlivex Therapeutics |
Amanet Management and Enlivex Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amanet Management and Enlivex Therapeutics
The main advantage of trading using opposite Amanet Management and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amanet Management position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.Amanet Management vs. Aran Research and | Amanet Management vs. Al Bad Massuot Yitzhak | Amanet Management vs. Gan Shmuel | Amanet Management vs. Analyst IMS Investment |
Enlivex Therapeutics vs. Israel Discount Bank | Enlivex Therapeutics vs. Amanet Management Systems | Enlivex Therapeutics vs. Bank Leumi Le Israel | Enlivex Therapeutics vs. Rimon Consulting Management |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |